Interview with our CEO, Pedro Moreo, on the support of the European Commission for the research line of organ preservation

Details

Published on Tuesday, 22 March 2022 13:28

EBERS wins tender to develop a new generation of ex vivo normothermic perfusion systems

Details

Published on Tuesday, 11 January 2022 07:06

EBERS has won a €2.4 million tender titled Pre-Commercial Procurement for the Development of Innovative Solutions in the Field of Organ Preservation, opened by the Spanish Center for the Development of Industrial Technology (CDTI). The works will be executed in collaboration with Moses Products, a company specialized in plastic transformation, and Intraven, an SME specialized in the assembly, packaging and sterilization of medical devices.

We summarize below the most relevant aspects of the contract:

• Name of the project: Compra pública precomercial para el desarrollo de soluciones innovadoras en el ámbito de la preservación de órganos (Expte. CPP 01/2021 AB).
• Place of execution: Cáceres/Zaragoza/Madrid
• Period of execution: June 2021-March 2023
• Budget: 2.4 M€.
• Co-funded by CDTI and FEDER: Project co-funded by the European Regional Development Fund (ERDF) in the framework of the 2014-2020 Pluri-Regional Operational Programme of Spain.
• Goal: Design and development of an ex vivo preservation system for solid organs beyond the state of the start, which can contribute to expand the organ donor pool for transplantation and reduce costs of healthcare systems

“Cutting-edge Regenerative Medicine” symposium

Details

Published on Friday, 26 November 2021 06:23

EBERS’ CEO, Pedro Moreo, participated in the symposium on “Cutting-edge Regenerative Medicine” organized by Clínica Universidad de Navarra and CIMA research institute. He gave his view on the current situation of organ transplantation and presented the latest results obtained in the NORMOPERF (normoperf.eu) project financed by the European Commission.

Annual meeting of the BRAVE EU project

Details

Published on Friday, 26 November 2021 06:20

This week it was celebrated the annual meeting of the BRAVE project (projectbrave.eu, @brav3_eu), led by Dr. Felipe Prósper from Clínica Universidad de Navarra. It was great to see and meet in person the rest of partners of the consortium and discover how much progress has been done so far. On EBERS’ side, it was exciting to show to the partners the new cell culture bioreactor that has been designed in collaboration with Leartiker and Boston Scientific, which is ready for the first cell culture validation tests.